The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases
Open accessAbstract
Radionecrosis is a well-characterized effect of stereotactic radiosurgery (SRS) and is occasionally associated with serious neurologic sequelae. Here, we investigated the incidence of and clinical variables associated with the development of radionecrosis and related radiographic changes after SRS for brain metastases in a cohort of patients with long-term follow up. 271 brain metastases treated with single-fraction linear accelerator-based SRS were analyzed. Radionecrosis was diagnosed either pathologically or radiographically. Univariate and multivariate Cox regression was performed to determine the association between radionecrosis and clinical factors available prior to treatment planning. After median follow up of 17.2 months, radionecrosis was observed in 70 (25.8 %) lesions, including 47 (17.3 %) symptomatic cases. 22 of 70 cases (31.4 %) were diagnosed pathologically and 48 (68.6 %) were diagnosed radiographically. The actuarial incidence of radionecrosis was 5.2 % at 6 months, 17.2 % at 12 months and 34.0 % at 24 months. On univariate analysis, radionecrosis was associated with maximum tumor diameter (HR 3.55, p < 0.001), prior whole brain radiotherapy (HR 2.21, p = 0.004), prescription dose (HR 0.56, p = 0.02) and histology other than non-small cell lung, breast or melanoma (HR 1.85, p = 0.04). On multivariate analysis, only maximum tumor diameter (HR 3.10, p < 0.001) was associated with radionecrosis risk. This data demonstrates that with close imaging follow-up, radionecrosis after single-fraction SRS for brain metastases is not uncommon. Maximum tumor diameter on pre-treatment MR imaging can provide a reliable estimate of radionecrosis risk prior to treatment planning, with the greatest risk among tumors measuring >1 cm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aoyama, H., Shirato, H., Tago, M., Nakagawa, K., Toyoda, T., Hatano, K., Kenjyo, M., Oya, N., Hirota, S., Shioura, H., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2483 · Cited by 2,213
Kocher, M., Soffietti, R., Abacioglu, U., Villà, S., Fauchon, F., Baumert, B. G., Fariselli, L., Tzuk-Shina, T., Kortmann, R.-D., Carrie, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1655 · Cited by 1,988
Shaw, E., Scott, C., Souhami, L., Dinapoli, R., Kline, R., Loeffler, J., & Farnan, N. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00507-6 · Cited by 1,608
Radiation Dose–Volume Effects in the Heart
Gagliardi, G., Constine, L. S., Moiseenko, V., Correa, C., Pierce, L. J., Allen, A. M., & Marks, L. B. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.04.093 · Cited by 1,227
Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
Minniti, G., Clarke, E., Lanzetta, G., Osti, M. F., Trasimeni, G., Bozzao, A., Romano, A., & Enrici, R. M. (2011) · Radiation Oncology · doi:10.1186/1748-717x-6-48 · Cited by 828
Radiation Dose–Volume Effects in the Brain
Lawrence, Y. R., Li, X. A., el Naqa, I., Hahn, C. A., Marks, L. B., Merchant, T. E., & Dicker, A. P. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.02.091 · Cited by 753
Levin, V. A., Bidaut, L., Hou, P., Kumar, A. J., Wefel, J. S., Bekele, B. N., Prabhu, S., Loghin, M., Gilbert, M. R., & Jackson, E. F. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.12.061 · Cited by 729
Bragg-peak proton-beam therapy for arteriovenous malformations of the brain
Kjellberg, R. N., Hanamura, T., Davis, K. R., Lyons, S. L., & Adams, R. D. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308043090503 · Cited by 540 · cited 2×
“It is important to note that multiple prior studies have reported relationships between dose-volume parameters and radionecrosis risk–first in the setting of arteriovenous malformation (AVM) [9, 23, 24] and subsequently in brain tumors treated with SRS [25].”
Blonigen, B. J., Steinmetz, R. D., Levin, L., Lamba, M. A., Warnick, R. E., & Breneman, J. C. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.006 · Cited by 506
Korytko, T., Radivoyevitch, T., Colussi, V., Wessels, B. W., Pillai, K., Maciunas, R. J., & Einstein, D. B. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.07.980 · Cited by 324
Complications from arteriovenous malformation radiosurgery: Multivariate analysis and risk modeling
Flickinger, J. C., Kondziolka, D., Pollock, B. E., Maitz, A. H., & Lunsford, L. D. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)89481-3 · Cited by 288
Barajas, R., Chang, J. S., Sneed, P. K., Segal, M. R., McDermott, M. W., & Cha, S. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1362 · Cited by 278
Variables associated with the development of complications from radiosurgery of intracranial tumors
Nedzi, L. A., Kooy, H., Alexander, E., Gelman, R. S., & Loeffler, J. S. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90675-t · Cited by 257
Five year results of linac radiosurgery for arteriovenous malformations: outcome for large AVMS
Miyawaki, L., Dowd, C., Wara, W., Goldsmith, B., Albright, N., Gutin, P., Halbach, V., Hieshima, G., Higashida, R., Lulu, B., et al. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00102-9 · Cited by 221
Self-citationPET in differentiation of recurrent brain tumor from radiation injury.
Langleben, D. D., & Segall, G. M. (2000) · PubMed · Cited by 210
Chin, L. S., Ma, L., & DiBiase, S. (2001) · Journal of Neurosurgery · doi:10.3171/jns.2001.94.6.0899 · Cited by 184
Flickinger, J. C., Lunsford, L. D., Kondziolka, D., Maitz, A. H., Epstein, A. H., Simons, S. R., & Wu, A. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)90539-t · Cited by 181
Risk analysis of linear accelerator radiosurgery
Voges, J., Treuer, H., Sturm, V., Büchner, C., Lehrke, R., Kocher, M., Staar, S., Kuchta, J., & Müller, R.-P. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00422-1 · Cited by 160
Fatterpekar, G. M., Galheigo, D., Narayana, A., Johnson, G., & Knopp, E. A. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.11.7417 · Cited by 144
Bělohlávek, O., Šimonová, G., Kantorová, I., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1011-2 · Cited by 96
Gasparetto, E. L., Pawlak, M. A., Patel, S. H., Huse, J. T., Woo, J. H., Krejza, J., Rosenfeld, M. R., O’Rourke, D. M., Lustig, R. A., Melhem, E. R., et al. (2009) · Radiology · doi:10.1148/radiol.2502071444 · Cited by 92
Barker, F. G., Butler, W. E., Lyons, S., Cascio, E., Ogilvy, C. S., Loeffler, J. S., & Chapman, P. H. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.2.0254 · Cited by 80
Enslow, M. S., Zollinger, L. V., Morton, K. A., et al. (2012) · Clinical Nuclear Medicine · doi:10.1097/rlu.0b013e318262c76a · Cited by 66
Ohtakara, K., Hayashi, S., Nakayama, N., Ohe, N., Yano, H., Iwama, T., & Hoshi, H. (2012) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0834-3 · Cited by 62
Cited by
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846
“116,117 Although many conventional or advanced imaging techniques have been investigated to distinguish true tumor from treatment-related changes, it remains challenging to spatially characterize heterogeneous tissues that often contain both viable tumor and treatment-related changes.”
BackgroundSafety of combining radiotherapy with immune-checkpoint inhibition
Hwang, W. L., Pike, L. R. G., Royce, T. J., Mahal, B. A., & Loeffler, J. S. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0046-7 · Cited by 295
Kaufmann, T. J., Smits, M., Boxerman, J., Huang, R., Barboriak, D. P., Weller, M., Chung, C., Tsien, C., Brown, P. D., Shankar, L., et al. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa030 · Cited by 267
Metadata
- Authors
- Kohutek, Z. A., Yamada, Y., Chan, T. A., Brennan, C. W., Tabar, V., Gutin, P. H., Jonathan Yang, T., Rosenblum, M. K., Ballangrud, Å., Young, R. J., Zhang, Z., & Beal, K.
- Venue
- Journal of Neuro-Oncology
- Published
- 2015-08-26
- Volume
- 125
- Issue
- 1
- Pages
- 149-156
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W1131275742
- Cited by
- 296
- References
- 24
- FWCI
- 14.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.